Liu, Y. (2022) “Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System”, Journal of Pharmacy & Pharmaceutical Sciences, 25, pp. 377–390. doi: 10.18433/jpps33020.